RESUMO
Periodontal defects present a significant challenge in dentistry, necessitating innovative solutions for comprehensive regeneration. Traditional restoration methods have inherent limitations in achieving complete and functional periodontal tissue reconstruction. Tissue engineering, a multidisciplinary approach integrating cells, biomaterials, and bioactive factors, holds tremendous promise in addressing this challenge. Central to tissue engineering strategies are scaffolds, pivotal in supporting cell behavior and orchestrating tissue regeneration. Natural and synthetic materials have been extensively explored, each offering unique advantages in terms of biocompatibility and tunable properties. The integration of growth factors and stem cells further amplifies the regenerative potential, contributing to enhanced tissue healing and functional restoration. Despite significant progress, challenges persist. Achieving the seamless integration of regenerated tissues, establishing proper vascularization, and developing biomimetic scaffolds that faithfully replicate the natural periodontal environment are ongoing research endeavors. Collaborative efforts across diverse scientific disciplines are essential to overcoming these hurdles. This comprehensive review underscores the critical need for continued research and development in tissue engineering strategies for periodontal regeneration. By addressing current challenges and fostering interdisciplinary collaborations, we can unlock the full regenerative potential, paving the way for transformative advancements in periodontal care. This research not only enhances our understanding of periodontal tissues but also offers innovative approaches that can revolutionize dental therapies, improving patient outcomes and reshaping the future of periodontal treatments.
RESUMO
Osteoarthritis is more prevalent than any other form of arthritis and is characterized by the progressive mechanical deterioration of joints. Glucosamine, an amino monosaccharide, has been used for over fifty years as a dietary supplement to alleviate osteoarthritis-related discomfort. Silibinin, extracted from milk thistle, modifies the degree of glycosylation of target proteins, making it an essential component in the treatment of various diseases. In this study, we aimed to investigate the functional roles of glucosamine and silibinin in cartilage homeostasis using the TC28a2 cell line. Western blots showed that glucosamine suppressed the N-glycosylation of the gp130, EGFR, and N-cadherin proteins. Furthermore, both glucosamine and silibinin differentially decreased and increased target proteins such as gp130, Snail, and KLF4 in TC28a2 cells. We observed that both compounds dose-dependently induced the proliferation of TC28a2 cells. Our MitoSOX and DCFH-DA dye data showed that 1 µM glucosamine suppressed mitochondrial reactive oxygen species (ROS) generation and induced cytosol ROS generation, whereas silibinin induced both mitochondrial and cytosol ROS generation in TC28a2 cells. Our JC-1 data showed that glucosamine increased red aggregates, resulting in an increase in the red/green fluorescence intensity ratio, while all the tested silibinin concentrations increased the green monomers, resulting in decreases in the red/green ratio. We observed increasing subG1 and S populations and decreasing G1 and G2/M populations with increasing amounts of glucosamine, while increasing amounts of silibinin led to increases in subG1, S, and G2/M populations and decreases in G1 populations in TC28a2 cells. MTT data showed that both glucosamine and silibinin induced cytotoxicity in TC28a2 cells in a dose-dependent manner. Regarding endoplasmic reticulum stress, both compounds induced the expression of CHOP and increased the level of p-eIF2α/eIF2α. With respect to O-GlcNAcylation status, glucosamine and silibinin both reduced the levels of O-GlcNAc transferase and hypoxia-inducible factor 1 alpha. Furthermore, we examined proteins and mRNAs related to these processes. In summary, our findings demonstrated that these compounds differentially modulated cellular proliferation, mitochondrial and cytosol ROS generation, the mitochondrial membrane potential, the cell cycle profile, and autophagy. Therefore, we conclude that glucosamine and silibinin not only mediate glycosylation modifications but also regulate cellular processes in human chondrocytes.
Assuntos
Condrócitos , Glucosamina , Homeostase , Fator 4 Semelhante a Kruppel , Espécies Reativas de Oxigênio , Silibina , Glucosamina/farmacologia , Glucosamina/metabolismo , Humanos , Silibina/farmacologia , Glicosilação/efeitos dos fármacos , Condrócitos/metabolismo , Condrócitos/efeitos dos fármacos , Homeostase/efeitos dos fármacos , Espécies Reativas de Oxigênio/metabolismo , Fator 4 Semelhante a Kruppel/metabolismo , Linhagem Celular , Proliferação de Células/efeitos dos fármacos , Mitocôndrias/metabolismo , Mitocôndrias/efeitos dos fármacos , Cartilagem/metabolismo , Cartilagem/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Osteoartrite/metabolismo , Osteoartrite/tratamento farmacológicoRESUMO
BACKGROUND CONTEXT: Favorable clinical outcomes of surgical treatment with Cotrel-Dubousset instrumentation (CDI) or instrumentations that follow the principles of CDI, for adolescent idiopathic scoliosis (AIS) have been reported. However, there are few studies concerning the results with rods of different sizes. PURPOSE: To find out whether the rod size affects the surgical results for AIS. STUDY DESIGN: A retrospective cohort study based on the same spinal system with different sizes of rod. PATIENT SAMPLE: A consecutive series of 93 patients, who underwent posterior correction with posterior instrumentation and fusion for AIS, were included and retrospectively analyzed. OUTCOME MEASURES: Postoperative radiologic outcomes were evaluated using coronal curves, percentage of curve correction, and coronal global balance. METHODS: Ninety-three patients treated during the period January 2000 to December 2008 were included in this study; 48 patients were treated with the Cotrel-Dubousset Horizon (CDH) M10 system with a 6.35-mm rod from January 2000 through December 2004, and a CDH M8 was used with a 5.5-mm rod in another 45 patients from January 2005 through December 2008. The Cobb angle, Risser grade, coronal curves, flexibility of curve, percentage of curve correction, coronal global balance, operative time, and estimated blood loss were measured and analyzed. The same parameters were used when the patient was followed at the OPD. All of the patients underwent regular follow-up for at least 2 years. RESULTS: No statistical significance was observed in the demographic data, including age, sex, BMI, and Risser grade, between these 2 groups. The overall average percentage of correction was 60.0%±12.7%: 60.7%±12.5% for the CDH M10 group, and 59%±13.1% for the CDH M8 group. At the final follow-up, the overall average loss of correction was 4.8±3.9° for the CDH M10 group, and 4.3±4.0° for the CDH M8 group. The average percentage of correction at the final follow-up was 50.9%±15.1% for the CDH M10 group, and 51.1%±16.1% for the M8 group. No statistical significance could be observed in the radiologic parameters between these 2 groups. CONCLUSION: The radiologic results for the 5.5-mm rod and the 6.35-mm rod were comparable in terms of correction, loss of correction, and coronal global balance.